Akoya BioSciencesAKYA
Market Cap: $139M
About: Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.
Employees: 330
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
0% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]
5% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 21
5.28% less ownership
Funds ownership: 30.36% [Q1] → 25.08% (-5.28%) [Q2]
13% less funds holding
Funds holding: 68 [Q1] → 59 (-9) [Q2]
56% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 16
59% less capital invested
Capital invested by funds: $70M [Q1] → $29M (-$41M) [Q2]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
Piper Sandler David Westenberg 60% 1-year accuracy 18 / 30 met price target | 42%upside $4 | Overweight Maintained | 13 Aug 2024 |
Morgan Stanley Tejas Savant 75% 1-year accuracy 12 / 16 met price target | 7%upside $3 | Equal-Weight Downgraded | 6 Aug 2024 |
Craig-Hallum Bill Bonello 100% 1-year accuracy 2 / 2 met price target | 149%upside $7 | Buy Maintained | 6 Aug 2024 |